Alkermes
Price & Volume
Stats
See more52W Range | $25.17-$36.48 |
Market Cap | $5.5B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $1.4B |
Revenue Growth (YoY) | -10.6% |
Gross Profit (12 Mos) | $1.2B |
Diluted EPS | $1.43 |
News
See moreYahoo Finance • 10 days ago
Alkermes Starts Phase 3 Orexin Trials As Narcolepsy Story Builds
Yahoo Finance • 12 days ago
These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target
Yahoo Finance • 12 days ago
Alkermes (ALKS) Nears 52-Week High on Increasing Orexin Receptor Market Interest
Yahoo Finance • 2 months ago
Alkermes plc Q4 2025 Earnings Call Summary
About
CEO | Mr. Richard F. Pops |
CFO | Mr. Joshua Reed M.B.A. |
Address | Connaught House, Dublin, Ireland, D04 C5Y6 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 2,050 |
